Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system.

Tsai YC, Maditz R, Kuo CL, Fishman PS, Shoemaker CB, Oyler GA, Weissman AM.

Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16554-9. doi: 10.1073/pnas.1008302107. Epub 2010 Sep 7.

2.

Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication.

Tsai YC, Kotiya A, Kiris E, Yang M, Bavari S, Tessarollo L, Oyler GA, Weissman AM.

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5158-E5166. doi: 10.1073/pnas.1621076114. Epub 2017 Jun 5.

3.

An innovative molecular detection tool for tracking and tracing Clostridium botulinum types A, B, E, F and other botulinum neurotoxin producing Clostridia based on the GeneDisc cycler.

Fach P, Fenicia L, Knutsson R, Wielinga PR, Anniballi F, Delibato E, Auricchio B, Woudstra C, Agren J, Segerman B, de Medici D, van Rotterdam BJ.

Int J Food Microbiol. 2011 Mar 1;145 Suppl 1:S145-51. doi: 10.1016/j.ijfoodmicro.2010.04.006. Epub 2010 Apr 8.

PMID:
20471128
5.

Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.

Adler M, Keller JE, Sheridan RE, Deshpande SS.

Toxicon. 2001 Feb-Mar;39(2-3):233-43.

PMID:
10978741
6.

Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.

Arndt JW, Chai Q, Christian T, Stevens RC.

Biochemistry. 2006 Mar 14;45(10):3255-62.

PMID:
16519520
7.

Accelerated neuronal cell recovery from Botulinum neurotoxin intoxication by targeted ubiquitination.

Kuo CL, Oyler GA, Shoemaker CB.

PLoS One. 2011;6(5):e20352. doi: 10.1371/journal.pone.0020352. Epub 2011 May 24.

8.

Uptake of botulinum neurotoxin into cultured neurons.

Keller JE, Cai F, Neale EA.

Biochemistry. 2004 Jan 20;43(2):526-32.

PMID:
14717608
9.

Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.

Kull S, Schulz KM, Weisemann J, Kirchner S, Schreiber T, Bollenbach A, Dabrowski PW, Nitsche A, Kalb SR, Dorner MB, Barr JR, Rummel A, Dorner BG.

PLoS One. 2015 Feb 6;10(2):e0116381. doi: 10.1371/journal.pone.0116381. eCollection 2015.

10.

Persistence of Botulinum neurotoxin inactivation of nerve function.

Shoemaker CB, Oyler GA.

Curr Top Microbiol Immunol. 2013;364:179-96. doi: 10.1007/978-3-642-33570-9_9.

11.

A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate.

Fang H, Luo W, Henkel J, Barbieri J, Green N.

Proc Natl Acad Sci U S A. 2006 May 2;103(18):6958-63. Epub 2006 Apr 24.

12.

Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A.

Pellett S, Tepp WH, Stanker LH, Band PA, Johnson EA, Ichtchenko K.

Biochem Biophys Res Commun. 2011 Feb 25;405(4):673-7. doi: 10.1016/j.bbrc.2011.01.093. Epub 2011 Feb 1.

13.

A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic.

Wang J, Zurawski TH, Meng J, Lawrence G, Olango WM, Finn DP, Wheeler L, Dolly JO.

J Biol Chem. 2011 Feb 25;286(8):6375-85. doi: 10.1074/jbc.M110.181784. Epub 2010 Dec 7.

14.

Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes.

Marshall KM, Bradshaw M, Pellett S, Johnson EA.

Biochem Biophys Res Commun. 2007 Sep 14;361(1):49-54. Epub 2007 Jul 20.

15.

Persistence of botulinum neurotoxin action in cultured spinal cord cells.

Keller JE, Neale EA, Oyler G, Adler M.

FEBS Lett. 1999 Jul 30;456(1):137-42.

16.

Unique substrate recognition by botulinum neurotoxins serotypes A and E.

Chen S, Barbieri JT.

J Biol Chem. 2006 Apr 21;281(16):10906-11. Epub 2006 Feb 14.

17.

Botulinum neurotoxin A and neurotoxin E cleavage products of synaptosome-associated protein of 25 kd exhibit distinct actions on pancreatic islet beta-cell Kv2.1 channel gating.

He Y, Elias CL, Huang YC, Gao X, Leung YM, Kang Y, Xie H, Chaddock JA, Tsushima RG, Gaisano HY.

Pancreas. 2008 Jan;36(1):10-7. doi: 10.1097/mpa.0b013e31812eee28.

PMID:
18192874
18.

Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells.

Whitemarsh RC, Tepp WH, Johnson EA, Pellett S.

PLoS One. 2014 Feb 27;9(2):e90252. doi: 10.1371/journal.pone.0090252. eCollection 2014.

19.

Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.

Vaidyanathan VV, Yoshino K, Jahnz M, Dörries C, Bade S, Nauenburg S, Niemann H, Binz T.

J Neurochem. 1999 Jan;72(1):327-37.

20.

Solubility of the catalytic domains of Botulinum neurotoxin serotype E subtypes.

Chen S, Barbieri JT.

Protein Expr Purif. 2016 Feb;118:18-24. doi: 10.1016/j.pep.2015.10.003. Epub 2015 Oct 22.

PMID:
26477500

Supplemental Content

Support Center